Long-term, heavy ketamine use is associated with memory problems, depression and anxiety. The drug may also cause ...

Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company developing innovative, best-in-class new chemical entities (NCEs) that tran ...

Relief Mental Health, an award-winning outpatient provider of innovative mental health services, proudly announces the ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...

A new systematic review published in the journal Cureus finds that psychedelic-assisted therapies such as ketamine, esketamine, and psilocybin may offer fast-acting and sustained relief for those with ...

But there’s no denying that it's seen a surge of interest in recent years. Ketamine clinics—or treatment centers that offer ...

Our favourite reality shows need a generous dose controversy to keep the audience engaged ... In 2019, America's Food and Drug Administration approved a nasal spray called esketamine, derived from ...

Jen celebrates Zac's openness in trying the unconventional therapy Season 2 of The Secret Lives of Mormon Wives picks up with ...

Detailed price information for Neuronetics Inc (STIM-Q) from The Globe and Mail including charting and trades.

The psychiatrist said patient can feel the effects of esketamine a few hours after receiving a dose. “Some hours later, many people report that their mood lifts on that day — not as we ...

Spravato, a nasal spray containing esketamine, is now subsidized in Australia for adults with treatment-resistant depression who have not responded to at least two other antidepressants.